Vorapaxar in the secondary prevention of atherothrombotic events

TRA 2P–TIMI 50 Steering Committee and Investigators, Graeme John Hankey

Research output: Contribution to journalArticlepeer-review

819 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Vorapaxar in the secondary prevention of atherothrombotic events'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science